JAN 03, 2017 8:30 PM PST

Dendritic Cell Vaccines Promising For Breast Cancer

WRITTEN BY: Kara Marker

A vaccine for cancer is on the horizon, although it works in a way different to what most people might consider a conventional vaccine. Using a personalized approach, scientists from the Moffitt Cancer Center are on the brink of a new treatment option for breast cancer patients.

Researchers tested the safety and efficacy of the new vaccine technology in a clinical trial with 54 women all diagnosed with early-stage breast cancer. The other quality these women shared was that their breast cancer cells expressed HER2, a protein that is overexpressed in nearly a quarter of all breast cancers and which is unfortunately linked to cases of a particularly aggressive cancer and a poor prognosis.

Expressing HER2 works for cancer cells because immune cells that are designed to fight tumors cannot recognize and target cancer cells as well when they display this protein on their cell surface, as if the immune system didn’t already have enough on its plate in a case of cancer.

This is where the idea came to create a vaccine of sorts, designed for dendritic cells. The vaccine helps the immune system relearn to recognize HER2, and researchers could extract dendritic cells from each breast cancer patient to cater a dendritic cell vaccine specifically to each person.

Vaccines in the clinical trial were reinjected into a lymph node, breast tumor, or both once a week for six weeks. Results showed that the treatment was well received and women experienced only low-grade toxicity, if any. Not many cancer treatments can say the same. Very few side effects occurred, with the most common being fatigue, injection site reactions, and chills.

Remarkably, researchers saw a clear immune response to the vaccine in 80 percent of evaluable patients, and all of the responses were similar despite variation of vaccine administration location.

"These results suggest that vaccines are more effective in [ductal carcinoma in situ (DCIS, an early non-invasive disease)], thereby warranting further evaluation in DCIS or other minimal disease settings, and the local regional sentinel lymph node may serve as a more meaningful immunologic endpoint," explained Brian J. Czerniecki, MD, PhD

The present study was published in the journal Clinical Cancer Research.

Source: Moffitt Cancer Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 13, 2020
Cell & Molecular Biology
The Immune Response to Infection and Vaccination Depends on Previous Infections
DEC 13, 2020
The Immune Response to Infection and Vaccination Depends on Previous Infections
After we are exposed to a pathogen or in the case of vaccines, a portion of a pathogen, our body mounts an immune respon ...
DEC 17, 2020
Immunology
A Peanut a Day Keeps Allergies Away
DEC 17, 2020
A Peanut a Day Keeps Allergies Away
Canadian researchers have made a breakthrough for children with peanut allergies: immunotherapy that when taken daily fo ...
DEC 27, 2020
Immunology
A Fatty Diet can be Fuel for Tumor Growth!
DEC 27, 2020
A Fatty Diet can be Fuel for Tumor Growth!
Obesity is a significant problem in our societies with increasing the risk for many diseases, including cancer. Can ...
JAN 06, 2021
Immunology
Probiotic Boosters Are Lifesavers for Preterm Babies
JAN 06, 2021
Probiotic Boosters Are Lifesavers for Preterm Babies
When administered shortly after birth, a recent study has found that the supplementation combo of probiotics and prebiot ...
JAN 19, 2021
Immunology
How Breastfeeding improves Infants Immunity?
JAN 19, 2021
How Breastfeeding improves Infants Immunity?
Breastfeeding benefits are well known for ages, and it has many positive impacts on infant's lives that continue wit ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
Loading Comments...